Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription

Articles published in BMC Neurosci

Retrieve available abstracts of 15 articles:
HTML format

Single Articles

    September 2021
  1. WEN J, Zhao M, Sun W, Cheng X, et al
    Uptake of Abeta by OATPs might be a new pathophysiological mechanism of Alzheimer disease.
    BMC Neurosci. 2021;22:53.
    PubMed     Abstract available

    August 2021
  2. KILE S, Au W, Parise C, Rose K, et al
    Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease.
    BMC Neurosci. 2021;22:49.
    PubMed     Abstract available

    May 2021
  3. RINGLAND C, Schweig JE, Eisenbaum M, Paris D, et al
    MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease.
    BMC Neurosci. 2021;22:39.
    PubMed     Abstract available

    July 2020
  4. MIAO J, Jing J, Shao Y, Sun H, et al
    MicroRNA-138 promotes neuroblastoma SH-SY5Y cell apoptosis by directly targeting DEK in Alzheimer's disease cell model.
    BMC Neurosci. 2020;21:33.
    PubMed     Abstract available

    July 2019
  5. NIMMY JOHN T, Subha Dharmapalan P, Ramshekhar Menon N
    Exploration of time-frequency reassignment and homologous inter-hemispheric asymmetry analysis of MCI-AD brain activity.
    BMC Neurosci. 2019;20:38.
    PubMed     Abstract available

    April 2019
  6. PANTHER P, Kuehne M, Voges J, Nullmeier S, et al
    Electric stimulation of the medial forebrain bundle influences sensorimotor gaiting in humans.
    BMC Neurosci. 2019;20:20.
    PubMed     Abstract available

    March 2019
  7. SAKAKIBARA Y, Sekiya M, Saito T, Saido TC, et al
    Amyloid-beta plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    BMC Neurosci. 2019;20:13.
    PubMed     Abstract available

    February 2019
  8. AL-ATRACHE Z, Lopez DB, Hingley ST, Appelt DM, et al
    Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of beta-amyloid found in Alzheimer disease.
    BMC Neurosci. 2019;20:6.
    PubMed     Abstract available

    November 2018
  9. KHALID S, Zahid MA, Ali H, Kim YS, et al
    Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.
    BMC Neurosci. 2018;19:74.
    PubMed     Abstract available

    October 2018
  10. SHABIR O, Berwick J, Francis SE
    Neurovascular dysfunction in vascular dementia, Alzheimer's and atherosclerosis.
    BMC Neurosci. 2018;19:62.
    PubMed     Abstract available

    July 2018
  11. SON HJ, Jeong YJ, Yoon HJ, Lee SY, et al
    Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer's disease with PET imaging agents (18)F-flutemetamol and (18)F-florbetaben.
    BMC Neurosci. 2018;19:45.
    PubMed     Abstract available

    June 2018
  12. CHANG YS, Wu YH, Wang CJ, Tang SH, et al
    Higher levels of thyroxine may predict a favorable response to donepezil treatment in patients with Alzheimer disease: a prospective, case-control study.
    BMC Neurosci. 2018;19:36.
    PubMed     Abstract available

    February 2018
  13. MAITI P, Paladugu L, Dunbar GL
    Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
    BMC Neurosci. 2018;19:7.
    PubMed     Abstract available

    January 2018
  14. QI XM, Wang C, Chu XK, Li G, et al
    Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer's disease.
    BMC Neurosci. 2018;19:2.
    PubMed     Abstract available

    October 2017
  15. KUMAR S, Chowdhury S, Kumar S
    In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    BMC Neurosci. 2017;18:76.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.